Webinars & e-learning courses All webinars

Antimicrobial therapy for urinary tract syndromes

Antimicrobial therapy for urinary tract syndromes
Antimicrobial therapy for urinary tract syndromes

The diagnosis and treatment of most cases of uncomplicated urinary tract infection (UTI) in dogs is straightforward and antimicrobial treatment is usually effective. However, some clinical cases are complicated by recurrence and the emergence of multi drug resistant (MDR) infections. Bacterial UTIs are a rare cause of lower urinary tract disease in cats. To minimize the emergence of MDR infection and to rationalize antimicrobial usage in the treatment of UTIs, guidelines have been developed (2011) and updated (2016). First line antibiotics for bacterial UTIs include amoxicillin and sulphonamde-trimethaprim. The current recommendation for treatment duration is 7 days but many clinicians believe shorter durations of treatment is likely to be effective.

A complicated UTI is an infection that occurs in a patient with a predisposing anatomic or functional abnormality. Recurrent UTIs, defined as three or more UTIs over 12 months, is also considered a complicated infection While some predisposing factors are easily identified (eg cystic calculi), predisposing factors cannot always be identified.

In small animals, the presence of positive urine cultures in patients without clinical signs of urinary tract disease is termed subclinical bacteriuria (SB). Many studies have identified SB in dogs with endocrinopathies, obesity, long term immunosuppression and spinal cord disease and in cats with CKD, hyperthyroidism and diabetes mellitus.

There are few studies on the long term outcomes associated with SB in dogs and cats. SB in cats is not significantly associated with creatinine concentration or with diabetic control. In short term studies, untreated SB in healthy adult dogs is not associated with development of clinical signs. In long term studies in non azotaemic, older cats, untreated SB was not adversely associated with survival.

Recording from 30.01.2019

Speaker:

Joanna_White.jpg

Joanna White

BVSC (HONS), DIPACVIM (INTERNAL MEDICINE), PHD

Joanna White graduated from the University of Sydney and spent 6 years in general practice prior to completing a PhD in feline kidney disease. She completed a residency in small animal internal medicine at Massey University and is a Diplomate of the American College Veterinary Internal Medicine and a member of the Australian College of Veterinary Scientists (feline).
Joanna is a registered small animal medical specialist, and, in addition, has completed a Masters in Veterinary Epidemiology researching asymptomatic bacterial urinary tract infections in cats.
Outside of her clinical workload, Joanna is a reviewer for several professional journals including the Journal of Veterinary Internal Medicine, the Journal of Feline Medicine and Surgery and the Journal of Veterinary Clinical Science. Joanna is also an Examiner at Fellowship (specialist) level for the feline and internal medicine chapters of the Australian and New Zealand College of Veterinary Scientists.
Joanna has a strong interest in research and has been the lead author of a number of published research studies into feline kidney diseases and urinary tract infections.

Booking information

Duration: 0:53 h
Speaker: Joanna White
from 1
57.60 US$
(inkl. tax)

You might also be interested in

E_26_06_25_The Cushings Conundrum- From Diagnosis to Nursing Care_300x200.png
Angela Rathman
1:00 h

The Cushings Conundrum: From Diagnosis to Nursing Care

Cushings can be a frustrating disease process to recognize, diagnose, and effectively treat. Angela Rathmann will talk about how nurses can improve the care and outcomes of these complicated patients.


Image 02.12 300x200 (1)300.jpg
02.12.2026 (UTC)
09:00 - 10:00 (UTC)

Anaesthesia Considerations for Thoracic Trauma Patients for Nurses

VN's play a vital role in the management of patients with thoracic trauma. In this webinar, Kate Hatcher will discuss approaches for safe and effective administration of anaesthesia in these challenging cases
Image temp 30.07 (1).png
Thierry Beths
0:45 h

Total Intravenous Anaesthesia - Where are we

Thierry Beths shares the latest in pharmacokinetics and in technology that allows us to provide TIVA in a more controlled way, targeting specific drug concentrations, resulting in more stable anaesthesia.